Cargando…
Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia
PURPOSE: To investigate which clinical factors and laboratory values are associated with high FDG uptake in the bone marrow and spleen on 2-deoxy-2-[18F]fluoro-d-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) in patients with bacteremia. METHODS: One hundred forty-five con...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113205/ https://www.ncbi.nlm.nih.gov/pubmed/33106925 http://dx.doi.org/10.1007/s00259-020-05071-8 |
_version_ | 1783690810427965440 |
---|---|
author | Pijl, Jordy P. Kwee, Thomas C. Slart, Riemer H. J. A. Yakar, Derya Wouthuyzen-Bakker, Marjan Glaudemans, Andor W. J. M. |
author_facet | Pijl, Jordy P. Kwee, Thomas C. Slart, Riemer H. J. A. Yakar, Derya Wouthuyzen-Bakker, Marjan Glaudemans, Andor W. J. M. |
author_sort | Pijl, Jordy P. |
collection | PubMed |
description | PURPOSE: To investigate which clinical factors and laboratory values are associated with high FDG uptake in the bone marrow and spleen on 2-deoxy-2-[18F]fluoro-d-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) in patients with bacteremia. METHODS: One hundred forty-five consecutive retrospective patients with bacteremia who underwent FDG-PET/CT between 2010 and 2017 were included. Mean standard uptake values (SUV(mean)) of FDG in bone marrow, liver, and spleen were measured. Bone marrow-to-liver SUV ratios (BLR) and spleen-to-liver SUV ratios (SLR) were calculated. Linear regression analyses were performed to examine the association of BLR and SLR with age, gender, hemoglobin, leukocyte count, platelets, glucose level, C-reactive protein (CRP), microorganism, days of antibiotic treatment before FDG-PET/CT, infection focus, use of immunosuppressive drugs, duration of hospital stay (after FDG-PET/CT), ICU admission, and mortality. RESULTS: C-reactive protein (p = 0.006), a cardiovascular or musculoskeletal focus of infection (p = 0.000 for both), and bacteremia caused by Gram-negative bacteria (p = 0.002) were independently and positively associated with BLR, while age (p = 0.000) and glucose level before FDG-PET/CT (p = 0.004) were independently and negatively associated with BLR. For SLR, CRP (p = 0.001) and a cardiovascular focus of infection (p = 0.020) were independently and positively associated with SLR, while age (p = 0.002) and glucose level before FDG-PET/CT (p = 0.016) were independently and negatively associated with SLR. CONCLUSION: High FDG uptake in the bone marrow is associated with a higher inflammatory response and younger age in patients with bacteremia. In patients with high FDG uptake in the bone marrow, a cardiovascular or musculoskeletal focus of infection is more likely than other foci, and the infection is more often caused by Gram-negative species. High splenic FDG uptake is associated with a higher inflammatory response as well, and a cardiovascular focus of infection is also more likely in case of high splenic FDG uptake. |
format | Online Article Text |
id | pubmed-8113205 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-81132052021-05-13 Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia Pijl, Jordy P. Kwee, Thomas C. Slart, Riemer H. J. A. Yakar, Derya Wouthuyzen-Bakker, Marjan Glaudemans, Andor W. J. M. Eur J Nucl Med Mol Imaging Original Article PURPOSE: To investigate which clinical factors and laboratory values are associated with high FDG uptake in the bone marrow and spleen on 2-deoxy-2-[18F]fluoro-d-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) in patients with bacteremia. METHODS: One hundred forty-five consecutive retrospective patients with bacteremia who underwent FDG-PET/CT between 2010 and 2017 were included. Mean standard uptake values (SUV(mean)) of FDG in bone marrow, liver, and spleen were measured. Bone marrow-to-liver SUV ratios (BLR) and spleen-to-liver SUV ratios (SLR) were calculated. Linear regression analyses were performed to examine the association of BLR and SLR with age, gender, hemoglobin, leukocyte count, platelets, glucose level, C-reactive protein (CRP), microorganism, days of antibiotic treatment before FDG-PET/CT, infection focus, use of immunosuppressive drugs, duration of hospital stay (after FDG-PET/CT), ICU admission, and mortality. RESULTS: C-reactive protein (p = 0.006), a cardiovascular or musculoskeletal focus of infection (p = 0.000 for both), and bacteremia caused by Gram-negative bacteria (p = 0.002) were independently and positively associated with BLR, while age (p = 0.000) and glucose level before FDG-PET/CT (p = 0.004) were independently and negatively associated with BLR. For SLR, CRP (p = 0.001) and a cardiovascular focus of infection (p = 0.020) were independently and positively associated with SLR, while age (p = 0.002) and glucose level before FDG-PET/CT (p = 0.016) were independently and negatively associated with SLR. CONCLUSION: High FDG uptake in the bone marrow is associated with a higher inflammatory response and younger age in patients with bacteremia. In patients with high FDG uptake in the bone marrow, a cardiovascular or musculoskeletal focus of infection is more likely than other foci, and the infection is more often caused by Gram-negative species. High splenic FDG uptake is associated with a higher inflammatory response as well, and a cardiovascular focus of infection is also more likely in case of high splenic FDG uptake. Springer Berlin Heidelberg 2020-10-26 2021 /pmc/articles/PMC8113205/ /pubmed/33106925 http://dx.doi.org/10.1007/s00259-020-05071-8 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Pijl, Jordy P. Kwee, Thomas C. Slart, Riemer H. J. A. Yakar, Derya Wouthuyzen-Bakker, Marjan Glaudemans, Andor W. J. M. Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia |
title | Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia |
title_full | Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia |
title_fullStr | Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia |
title_full_unstemmed | Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia |
title_short | Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia |
title_sort | clinical implications of increased uptake in bone marrow and spleen on fdg-pet in patients with bacteremia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113205/ https://www.ncbi.nlm.nih.gov/pubmed/33106925 http://dx.doi.org/10.1007/s00259-020-05071-8 |
work_keys_str_mv | AT pijljordyp clinicalimplicationsofincreaseduptakeinbonemarrowandspleenonfdgpetinpatientswithbacteremia AT kweethomasc clinicalimplicationsofincreaseduptakeinbonemarrowandspleenonfdgpetinpatientswithbacteremia AT slartriemerhja clinicalimplicationsofincreaseduptakeinbonemarrowandspleenonfdgpetinpatientswithbacteremia AT yakarderya clinicalimplicationsofincreaseduptakeinbonemarrowandspleenonfdgpetinpatientswithbacteremia AT wouthuyzenbakkermarjan clinicalimplicationsofincreaseduptakeinbonemarrowandspleenonfdgpetinpatientswithbacteremia AT glaudemansandorwjm clinicalimplicationsofincreaseduptakeinbonemarrowandspleenonfdgpetinpatientswithbacteremia |